清华大学在全球大学2021年美国授权专利百强名单中排名第10；诺基亚将在中国面临多场诉讼
编辑制作：China IP 国际部
Overview
一周概览
Focus
1. Tsinghua University ranked the 10th in the ranking of Top 100 Worldwide Universities Granted U.S. Utility Patents
清华大学在全球大学2021年美国授权专利百强名单中排名第10
2. Global Innovation Index’s Global Science & Technology Clusters: East Asia Dominates Top Ranking
WIPO：全球创新指数之全球科技集群-东亚主导
3. KIPO: MEC patent applications surged in IP5
韩知识产权局：全球五大专利局边缘计算专利申请激增
IP Practice
4. Google to face €25 billion claims in Netherlands, UK over adtech allegations
谷歌因广告技术指控将在荷兰和英国面临250亿欧元索赔
5. Skechers settles trademark fight with Brooks Running over '5' logo
Skechers与Brooks就运动鞋“5”形logo商标侵权一案达成和解
6. Gilead settles patent fight with generic drugmakers over HIV drugs
吉利德与仿制药制造商就艾滋病药物的专利争夺达成和解
7. Former Broadcom engineer charged with trade secret infringement and asks for a lighter penalty
前博通工程师被控侵犯商业秘密，请求量刑从轻
8. Cisco faces U.S. Supreme Court appeal after overturning $2.7 bln patent award
思科在27亿赔偿被推翻后将应对美最高院上诉
9. Nokia has multiple lawsuits to face in China
诺基亚将在中国面临多场诉讼
10. Swiss competition watchdog probes Novartis over patent use
瑞士竞争监督机构就专利使用问题对Novartis进行调查
Case Analysis
11. 典型案例——斐珞尔洁面仪外观设计专利侵权纠纷案
Focus
1
Tsinghua University ranked the 10th in the ranking of Top 100 Worldwide Universities Granted U.S. Utility Patents
清华大学在全球大学2021年美国授权专利百强名单中排名第10
On September 8, 2022, National Academy of Inventors (NAI) and Intellectual Property Owners Association (IPO) jointly released the annual report of Top 100 Worldwide Universities Granted U.S. Utility Patents, which has been published continuously since 2013. The report is based on data from U.S. Patent and Trademark Office (USPTO) for 2021 patent grants. The largest number of universities entering the list are located in the United States (63), followed by those located in China (18), with South Korea and Japan coming in third and fourth on the list. The top3 universities in the list are University of California (589 pieces), Massachusetts Institute of Technology (335 pieces), and University of Texas (203 pieces), all from the U.S, while Tsinghua University in China ranks the 10th.
2022年9月8日，美国国家发明家学院和知识产权所有者协会联合发布顶尖大学专利权人年度报告，公布了2021年全球大学美国授权专利Top 100排名，该排名自2013年以来持续发布。该报告是基于美国专利商标局（USPTO）2021年专利授权数据编制的。进入该榜单的大学中，位于美国的大学（63家）最多，其次是位于中国的大学（18家），韩国、日本则分列榜单第三、第四。该榜单中top3的大学分别是加州大学（589件）、麻省理工学院（335件）、德克萨斯大学（203件），均来自美国，而我国的清华大学名列榜单第10。
2
Global Innovation Index’s Global Science & Technology Clusters: East Asia Dominates Top Ranking
WIPO：全球创新指数之全球科技集群-东亚主导
On September 29, the World Intellectual Property Organization (WIPO) will release the 2022 edition of the WIPO Global Innovation Index (GII), and this week, the organization gave a sneak preview of some of the information - four of the world's top five technology clusters are located in East Asia --One in Japan, two in China, one in the Republic of Korea, and the fifth in the United States. Tokyo-Yokohama is the biggest cluster, followed by the Shenzhen-Hong Kong-Guangzhou (China and Hong Kong, China), Beijing (China), Seoul (Republic of Korea) and San Jose-San Francisco (United States) clusters.
9月29日，世界知识产权组织即将发布2022版全球创新指数（GII）。而本周，世界知识产权组织提前“剧透“了部分信息——世界五大科技集群中有四个位于东亚——日本一个，中国两个，大韩民国一个，第五个在美国。其中，东京-横滨是最大的集群，其次是深圳-香港-广州（中国和中国香港）、北京（中国）、首尔（大韩民国）和圣何塞-旧金山（美国）集群。
3
KIPO: MEC patent applications surged in IP5
韩知识产权局：全球五大专利局边缘计算专利申请激增
On September 5, 2022, the Korea Intellectual Property Office (KIPO) released patent statistics for Multi-Access Edge Computing (MEC), as the average annual growth rate of patent applications in this field reaches 58% in the last five years in the world's top five patent offices (IP5), surging from 294 in 2016 to 1,848 in 2020, an increase of more than six times. According to the data, in terms of the MEC patent applications proportion in IP5, China is the highest, accounting for 36.2% of all applications, followed by the US (32.6%), Europe (12.9%), Korea (12.2%) and Japan (6.0%). And among the ranking of corporate MEC patent applicants, Huawei (548) takes the lead, Samsung Electronics (459), Nokia (445), Intel (336) gain the second to the fourth place respectively.
2022年9月5日，韩国知识产权局（KIPO）发布多接入边缘计算（MEC, Muti-Access Edge Computing）专利统计数据，近五年世界五大专利局（IP5）在该领域的专利申请年均增长率达到58%，从2016年的294件激增至2020年1848件，增加了6倍以上。根据该数据统计，从IP5的MEC专利申请占比来看，中国最高，占全部申请数量的36.2%，其后依次为美国（32.6%）、欧洲（12.9%）、韩国（12.2%）、日本（6.0%）。企业MEC专利申请人排名则依次为华为（548件）、三星电子（459件）、诺基亚（445件）、英特尔（336件）。
IP Practice
4
Google to face €25 billion claims in Netherlands, UK over adtech allegations
谷歌因广告技术指控将在荷兰和英国面临250亿欧元索赔
Tech giant Google (Alphabet) is facing damages claims of up to 25 billion euros in two collective lawsuits announced on September 13. The claims are expected to be officially filed next week. The two cases are being brought on behalf of publishers in the United Kingdom and the European Union who say they have been harmed by the Alphabet subsidiary due to its digital advertising practices. The allegations include a claim that Google has distorted competition around its own bidding auction technique for online advertisements, and Google itself benefited financially from this, at the expense of publishers.
9月13日，科技巨头谷歌将在两起集体诉讼中面临高达250亿欧元的索赔要求。预计，该索赔将于下周正式提交至法院。这两起案件是代表英国出版商和欧盟出版商提起的，他们认为，谷歌的数字广告运作模式，使出版商们受到了Alphabet子公司的侵害。诉讼中的指控包括指控谷歌利用自己的在线广告竞价拍卖技术破坏公平竞争。使谷歌自己从中获得经济利益，却以牺牲出版商利益为代价。
5
Skechers settles trademark fight with Brooks Running over '5' logo
Skechers与Brooks就运动鞋“5”形logo商标侵权一案达成和解
On September 14, Skechers USA Inc and Berkshire Hathaway's Brooks Sports Inc have settled a trademark infringement lawsuit, according to a filing in Los Angeles federal court. Skechers sued Brooks for trademark infringement in June over running shoes including Brooks' Levitate 5, Revel 5 and Caldera 5 models, claiming the Brooks '5' logo on the tongues of its shoes in a way that resembles how Skechers uses its stylized "S", and was likely to confuse consumers. But this week, it asked the court to permanently dismiss the case, saying a settlement had been reached.
9月14日，根据洛杉矶联邦法院的一份法律文件，Skechers USA Inc和Berkshire Hathaway旗下的Brooks Sports Inc已经就一起商标侵权诉讼达成和解。先前，在6月，Skechers起诉Brooks侵犯其商标权，称Brooks在跑鞋的鞋舌上使用的数字"5"与Skechers的"S"标志过于相像，极可能混淆消费者，涉事的跑鞋包括Brooks的Levitate 5、Revel 5和Caldera 5的型号。但本周，Skechers请求法院永久撤回此案，并称两方公司已就此案达成了和解。
6
Gilead settles patent fight with generic drugmakers over HIV drugs
吉利德与仿制药制造商就艾滋病药物的专利争夺达成和解
Gilead Sciences Inc has settled patent disputes with five drugmakers over proposed generic versions of its blockbuster HIV drugs Descovy and Odefsey and hepatitis B drug Vemlidy, it said on September 12, in a filing with the U.S. Securities and Exchange Commission. Generic drugmakers Apotex Inc, Lupin Ltd, Cipla Ltd, Macleods Pharmaceuticals Ltd and Hetero Labs Ltd will receive non-exclusive licenses to the patents, allowing them to sell generic versions of the HIV drugs starting in October 2031 and Vemlidy in January 2032, according to the filing. Earlier, Gilead sued the drugmakers for infringement after they requested U.S. Food and Drug Administration approval for their proposed generics. The company requested a ruling that its patents were valid and an order to block the generics until they expired.
吉利德科学公司在9月12日提交给美国证券交易委员会的文件中称，其与五家制药商就其拟提交批准的仿制药版本抗艾滋病有效药Descovy和Odefsey以及抗乙肝药物Vemlidy的专利纠纷案达成了和解。据该文件，仿制药制造商Apotex Inc、Lupin Ltd、Cipla Ltd、Macleods Pharmaceuticals Ltd和Hetero Labs Ltd将获得这些专利的非独家许可，允许他们从2031年10月开始销售艾滋病药物的仿制药，以及从2032年1月开始销售Vemlidy。早前，吉利德在这些制药商要求美国食品和药物管理局批准其仿制药后，对这些制药商的侵权行为提起了上诉。该公司要求裁定其专利有效，并请求法院在专利权存续期间禁止这些仿制药的生产。
7
Former Broadcom engineer charged with trade secret infringement and asks for a lighter penalty
前博通工程师被控侵犯商业秘密，请求量刑从轻
On September 14, a former Broadcom engineer Peter Kisang Kim asked a California federal court for no prison time, he requested to be imposed six months of home confinement, unpaid community service and a three-year probation sentence instead, for he did not take the files for malicious reasons but out of fear he might forget things from his past work. Kim contends that he never used any of the information contained in the documents during his employment at Mersenne. Previously, Kim was accused of stealing 18 Broadcom trade secrets and taking the confidential information to Mersenne, a China-based startup.
9月14日消息，前博通工程师Peter Kisang Kim（以下简称Kim）要求加州联邦法院不要对他判处为期15个月的监禁。Kim请求对其实施6个月的家庭监禁、无偿社区服务，附加三年缓刑考察期，原因是自己并非恶意窃取博通文件，而是担心忘记之前工作中的相关内容。Kim辩称自己在Mersenne工作期间从未利用过这些文件中所包含的任何信息。此前，Kim被指控窃取了18项博通的商业机密，并将这些机密信息带到了一家总部位于中国的初创公司Mersenne。
8
Cisco faces U.S. Supreme Court appeal after overturning $2.7 bln patent award
思科在27亿赔偿被推翻后将应对美最高院上诉
On September 13, Centripetal Networks Inc said in an appeal to the U.S. Supreme Court that a U.S. appeals court improperly overturned a $2.7 billion patent judgment against Cisco Systems Inc based on a federal judge's perceived conflict of interest. The U.S. Court of Appeals for the Federal Circuit in June threw out the damages award for Centripital, which was the largest in the history of U.S. patent law, finding that late U.S. District Judge Henry Morgan should have recused himself or sold his wife's stock in Cisco after he learned of it during the case.
9月13日，Centripetal Networks Inc在向美国最高法院提出的上诉中说，美国上诉法院以一名联邦法官被认为存在利益冲突为由而不当推翻了对思科公司的27亿美元赔偿的专利判决。此前6月，美国联邦巡回上诉法院推翻了Centripital公司获赔偿金的判决，由于法院认为已故美国地区法官亨利-摩根在案件审理过程中得知思科公司的股票后应该回避或出售其妻子的股票却没有实施这些行为故判决存在程序瑕疵。这原是美国专利法历史上数额最大的赔偿金。
9
Nokia has multiple lawsuits to face in China.
诺基亚将在中国面临多场诉讼
According to the court session announcement, Nokia will be involved in several lawsuits in China in the next two months. On September 7, after the Chinese Supreme People's Court ruled in favor of OPPO on the jurisdictional objection in the OPPO v Nokia case, the date for the continuation of the case in Chongqing No. 1 Intermediate Court has also been specified, with a second trial scheduled for October 27. While on September 21, the patent dispute between Nokia and vivo will be heard in Hangzhou. Additionally, another patent dispute between Nokia and Vivo will be heard in Jinan Intermediate Court, but the trial date for the case has not yet been determined.
根据法院的开庭公告，在接下来的两个月中，诺基亚将在国内参与数起诉讼。9月7日，在中国最高人民法院对OPPO v. 诺基亚案的管辖权异议做出有利于OPPO的裁决后，重庆一中院对本案的继续审理日期也已经出炉，定于10月27日进行第二次庭审。而在9月21日，诺基亚与vivo的专利纠纷则将在杭州开庭。此外，诺基亚与vivo的另一起专利纠纷案件将在济南中院进行审理，但目前，案件的开庭审理时间尚未确定。
10
Swiss competition watchdog probes Novartis over patent use
瑞士竞争监督机构就专利使用问题对Novartis进行调查
The Swiss competition commission (COMCO) has opened an investigation of Novartis (NOVN.S) over possible unlawful use of a patent to reduce competitive pressure, the Swiss drugmaker confirmed on September 15. COMCO conducted an early morning raid on the company on Sept. 13, it said in a statement that did not name Novartis, which subsequently said in its own statement that it was the group under investigation. "The company allegedly attempted to protect its drug for the treatment of skin diseases against competing products by using one of its patents to initiate litigation proceedings," COMCO said in a statement.
瑞士制药商Novartis于9月15日证实，瑞士竞争委员会(COMCO)已对其发起了调查，原因是该公司涉嫌非法利用一项专利来减少竞争压力。COMCO在一份声明中称，在9月13日清晨，其对“某”公司进行了突击检查，但在该声明中并未提及Novartis的名称。但Novartis随后在自己的声明中说它就是被调查的集团。COMCO在一份声明中称，“该公司（Novartis）被认为试图通过利用其一项专利多次提起诉讼，以保护其治疗皮肤病的药物不受竞争产品的影响”。
Case Analysis
11
This case has, based on the protection of innovation factors and from the design space, defined the protection scope of design patent claims for color requesting protection and the principle of infringement comparison, which is conducive to the protection of innovative design, and of strong typical significance for the trial of similar cases.
本案基于对创新因素的保护，从设计空间出发，对于请求保护颜色的外观设计专利权利要求保护范围的确定以及侵权比对原则进行了明确，有利于保护创新性设计，对同类案件的审理也具有较强的典型意义。
英文投稿及市场合作：
jane.jiang@chinaipmagazine.com
18911449529（微信同号）